Small cell lung cancer: Can recent advances in biology and molecular biology be translated into improved outcomes?

Paul A. Bunn, John D. Minna, Alexander Augustyn, Adi F. Gazdar, Youcef Ouadah, Mark A. Krasnow, Anton Berns, Elisabeth Brambilla, Natasha Rekhtman, Pierre P. Massion, Matthew Niederst, Martin Peifer, Jun Yokota, Ramaswamy Govindan, John T. Poirier, Lauren A. Byers, Murry W. Wynes, David G. McFadden, David MacPherson, Christine L. HannAnna F. Farago, Caroline Dive, Beverly A. Teicher, Craig D. Peacock, Jane E. Johnson, Melanie H. Cobb, Hans Guido Wendel, David Spigel, Julien Sage, Ping Yang, M. Catherine Pietanza, Lee M. Krug, John Heymach, Peter Ujhazy, Caicun Zhou, Koichi Goto, Afshin Dowlati, Camilla Laulund Christensen, Keunchil Park, Lawrence H. Einhorn, Martin J. Edelman, Giuseppe Giaccone, David E. Gerber, Ravi Salgia, Taofeek Owonikoko, Shakun Malik, Niki Karachaliou, David R. Gandara, Ben J. Slotman, Fiona Blackhall, Glenwood Goss, Roman Thomas, Charles M. Rudin, Fred R. Hirsch

Research output: Contribution to journalReview articlepeer-review

96 Scopus citations
Original languageEnglish (US)
Pages (from-to)453-474
Number of pages22
JournalJournal of Thoracic Oncology
Volume11
Issue number4
DOIs
StatePublished - 2016

Keywords

  • Gene mutations
  • Immunotherapy
  • Neuroendocrine
  • Small cell lung cancer
  • Therapy

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this